Advancing Genetic
Diagnostics for
Precise Medicine.

Impact Genetics provides cost-effective, high quality genetic testing for select diseases.

In collaboration with our leading scientists and clinical care providers, we continually refine tests to maximize sensitivity. New scientific discoveries, genetic data and clinical knowledge flow freely to maximize health impact. Impact Genetics’ service delivery team is committed to supporting doctors and genetic specialists with outstanding service.

  • November 28th, 2017 – Impact Genetics launches Tumor MMR Sequencing and deletion/duplication Test. This test is used to both confirm and rule out Lynch Syndrome by diagnosing biallelic somatic MMR cancer. MMR analysis can be performed on a variety of tumor types (endometrial, colon, etc.) and uses advanced next-generation sequencing and copy number analysis (using MLPA) for MLH1, MSH2, MSH6, PMS2 and EPCAM. More information.

Joan-clip

Joan’s Story – Uveal Melanoma Prognostic Genetic Testing

Joan speaks about her decision to undergo prognostic UM tumor testing. This is followed by interviews with Dr. Tara McCannel (UCLA) and Dr. Bertil Damato (UCSF) who discuss how they use results of UM genetic testing and the importance of this testing to their patients.

 

Dynacare Centre for Precision Diagnostics – Bowmanville, Ontario

Specialized scientists, Impact Genetics and Dynacare are working together to support healthy lives around the world. The Dynacare Centre for Precision Diagnostics in Bowmanville, Ontario has partnered with internationally sought-after Canadian scientists to provide cutting-edge genetic test solutions globally.

 

Why choose us?
  • Cost effective
  • Documented high diagnostic sensitivity
  • Provided by disease experts
  • Flexible billing and personal support
  • Quick turn-around times
  • Comprehensive and informative reports

More about our services

News and Events
NOV 28th – Impact Genetics launches Tumor MMR Sequencing
and Deletion/Duplication Genetic Test. More Information.
MAR 23rd – Impact Genetics launches BAP1 Tumor Predisposition Syndrome (BAP1-TPDS) Genetic Test. More Information.
MAR 16th – Now Available: Faster test turn around times, updated and improved test order forms. More Information.

More news and events